Issues related to pharmaceuticals and drug development.
2026 · 2nd Quarter (Apr 1 - June 30)
GILEAD SCIENCES, INC.
Filed by MILLER STRATEGIES, LLC.
Open official filingSource-reported fields
Filing overview
- Type
- 2nd Quarter - Report
- Posted
- Jul 20, 2026
- Income
- $150,000.00
- Expenses
- Not reported
- Registrant
- MILLER STRATEGIES, LLC
- Client
- GILEAD SCIENCES, INC.
- Filing UUID
- 90d7ec2e-85c8-4e32-984a-1edea46d959e
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Issues related to pharmaceuticals and drug development.
Issues related to pharmaceuticals and drug development.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.